Figure 2.
Decrease (Δ) in central retinal thickness (CRT) (μm) after repeated 1.25 mg bevacizumab injections in patients with neovascular age-related macular degeneration.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.